Case number 1:17-cv-01219
ELI LILLY AND COMPANY et al v. PAR PHARMACEUTICAL, INC. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 6, 2018 | 22 | CLOSED DISMISSED. Acknowledges Notice of Dismissal (Marginal Notation) - NOTICE IS HEREBY GIVEN that Eli Lilly and Company, Eli Lilly Export S.A., andAcrux DDS Pty Ltd., by and through undersigned counsel, hereby voluntarily dismiss the above-captioned case without prejudice pursuant to Rule 41(a)(1)(A) (i) of the Federal Rules of Civil Procedure. Rule 41(a)(1)(A)(i) is applicable because the defendant in this action has served neither an answer nor a motion for summary judgment. Each party to the action will bear its own costs and attorneys' fees. Signed by Judge William T. Lawrence on 2/6/2018. (JDC) (Entered: 02/06/2018) (2) |
| Nov 30, 2017 | 21 | NOTICE of Voluntary Dismissal, filed by Plaintiffs ACRUX DDS PTY LTD, ELI LILLY AND COMPANY, ELI LILLY EXPORT S.A.. (DePrez, Anne) (Entered: 11/30/2017) (2) |
| Aug 8, 2017 | 20 | ORDER REASSIGNING CASE - Pursuant to 28 U.S.C. Section 137 and Local Rule 40-1(f), this matter has been reassigned to Magistrate Judge Mark J. Dinsmore. Judge Denise K. LaRue is no longer assigned to the case. Please include the new case number,1:17-cv-01219-WTL-MJD, on all future filings in this matter. Signed by Judge Jane Magnus-Stinson on 8/8/2017. (RSF) (Entered: 08/08/2017) (1) |
| May 17, 2017 | 19 | ORDER granting Plaintiff's 18 Motion to Stay Pending Resolution of Related Case. Stay this action and hold all deadlines in abeyance pending a final decision on the merits of the Federal Circuit in the appeal of Eli Lillyand Company et al. v. Perrigo Company, et al., No. 1:13-cv-00851-SEB-DKL (S.D. Ind.) ("the Perrigo Litigation"). Signed by Judge William T. Lawrence on 5/17/2017. (JDC) (Entered: 05/17/2017) (1) |
| May 16, 2017 | 18 | Joint MOTION to Stay Pending Resolution of Related Case, filed by Plaintiffs ACRUX DDS PTY LTD, ELI LILLY AND COMPANY, ELI LILLY EXPORT S.A.. (Attachments: # 1 Text of Proposed Order)(DePrez, Anne) (Entered: 05/16/2017) (0) |
| May 9, 2017 | 17 | NOTICE of Appearance by Jeffrey N. Furminger on behalf of Defendants PAR PHARMACEUTICAL, INC., PAR PHARMACEUTICALS COMPANIES, INC.. (Furminger, Jeffrey) (Entered: 05/09/2017) (2) |
| May 9, 2017 | 16 | Corporate Disclosure Statement by PAR PHARMACEUTICAL, INC., PAR PHARMACEUTICALS COMPANIES, INC. identifying Corporate Parent ENDO INTERNATIONAL PLC for PAR PHARMACEUTICAL, INC., PAR PHARMACEUTICALS COMPANIES, INC... (Cohen, Hamish) (Entered: 05/09/2017) (2) |
| May 9, 2017 | 15 | NOTICE of Parties' First Extension of Time, filed by Defendants PAR PHARMACEUTICAL, INC., PAR PHARMACEUTICALS COMPANIES, INC.. (Cohen, Hamish) (Entered: 05/09/2017) (3) |
| May 9, 2017 | 14 | NOTICE of Appearance by Hamish S. Cohen on behalf of Defendants PAR PHARMACEUTICAL, INC., PAR PHARMACEUTICALS COMPANIES, INC.. (Cohen, Hamish) (Entered: 05/09/2017) (2) |
| May 5, 2017 | 13 | RETURN of Service, filed by All Plaintiffs. PAR PHARMACEUTICALS COMPANIES, INC. served on 5/5/2017. (Attachments: # 1 Exhibit A - USPS Tracking Information)(DePrez, Anne) (Entered: 05/05/2017) (0) |
| May 2, 2017 | 12 | NOTICE of Initial Filing in lawsuit sent to Director of U.S. Patent and Trademark Office. (Attachments: # 1 Complaint, # 2 Exhibit A - Patent 944, # 3 Exhibit B - Patent 520, # 4 Exhibit C - Patent 194, # 5 Exhibit D - Patent 307, # 6 Exhibit E - Patent 449, # 7 Exhibit F - Patent 861, # 8 Exhibit G - Patent 586) (JDC) (Entered: 05/02/2017) (0) |
| Apr 27, 2017 | 11 | Summons Issued as to PAR PHARMACEUTICAL, INC., PAR PHARMACEUTICALS COMPANIES, INC. (LAB) (JDC) (Entered: 04/27/2017) (1) |
| Apr 26, 2017 | 10 | RETURN of Service, filed by All Plaintiffs. PAR PHARMACEUTICAL, INC. served on 4/25/2017. (Attachments: # 1 Exhibit USPS Tracking Information)(DePrez, Anne) (Entered: 04/26/2017) (0) |
| Apr 18, 2017 | 1 | Main Document (33) |
| Apr 18, 2017 | 1 | Exhibit A - Patent 944 (18) |
| Apr 18, 2017 | 2 | Notice of Appearance (1) |
| Apr 18, 2017 | 2 | Exhibit B - Patent 520 (20) |
| Apr 18, 2017 | 1 | Main Document (33) |
| Apr 18, 2017 | 3 | Exhibit C - Patent 194 (21) |
| Apr 18, 2017 | 1 | Exhibit A - Patent 944 (18) |
| Apr 18, 2017 | 6 | Exhibit F - Patent 861 (15) |
| Apr 18, 2017 | 4 | Exhibit D - Patent 307 (15) |
| Apr 18, 2017 | 2 | Exhibit B - Patent 520 (20) |
| Apr 18, 2017 | 5 | Exhibit E - Patent 449 (14) |
| Apr 18, 2017 | 3 | Exhibit C - Patent 194 (21) |
| Apr 18, 2017 | 2 | Notice of Appearance (1) |
| Apr 18, 2017 | 4 | Notice (Other) (1) |
| Apr 18, 2017 | 4 | Exhibit D - Patent 307 (15) |
| Apr 18, 2017 | 7 | Exhibit G - Patent 586 (15) |
| Apr 18, 2017 | 5 | Exhibit E - Patent 449 (14) |
| Apr 18, 2017 | 8 | Civil Cover Sheet (2) |
| Apr 18, 2017 | 6 | Exhibit F - Patent 861 (15) |
| Apr 18, 2017 | 9 | Proposed Summons (2) |
| Apr 18, 2017 | 7 | Exhibit G - Patent 586 (15) |
| Apr 18, 2017 | 8 | Civil Cover Sheet (2) |
| Apr 18, 2017 | 9 | Proposed Summons (2) |
| Apr 18, 2017 | 4 | Notice (Other) (1) |
| Apr 18, 2017 | 3 | Corporate Disclosure Statement (1) |
| Apr 18, 2017 | 4 | Notice (Other) (1) |
| Apr 18, 2017 | 9 | Proposed Summons (2) |
| Apr 18, 2017 | 3 | Corporate Disclosure Statement (1) |
| Apr 18, 2017 | 1 | Main Document (33) |
| Apr 18, 2017 | 8 | Civil Cover Sheet (2) |
| Apr 18, 2017 | 3 | Corporate Disclosure Statement (1) |
| Apr 18, 2017 | 7 | Exhibit G - Patent 586 (15) |
| Apr 18, 2017 | 6 | Exhibit F - Patent 861 (15) |
| Apr 18, 2017 | 5 | Exhibit E - Patent 449 (14) |
| Apr 18, 2017 | 2 | Notice of Appearance (1) |
| Apr 18, 2017 | 4 | Exhibit D - Patent 307 (15) |
| Apr 18, 2017 | 3 | Exhibit C - Patent 194 (21) |
| Apr 18, 2017 | 2 | Exhibit B - Patent 520 (20) |
| Apr 18, 2017 | 1 | Exhibit A - Patent 944 (18) |
| Apr 18, 2017 | 1 | Complaint* (1) |
